• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
a lot of scissors
Biotech

Amgen sheds around 40 staffers as struggles mount

The layoffs are part of “organizational changes” meant to better align operations with the company’s strategic objectives.
Darren Incorvaia Jul 24, 2026 4:45pm
x

Fierce Biotech Layoff Tracker 2026: Amgen, Clinuvel & more

Jul 24, 2026 4:00pm
Red flag on a beach with a storm coming

Study reveals genetic red flags for CAR-T therapy side effects

Jul 24, 2026 2:00pm
handshake deal shake hand arrows ok yes
Favicon Fierce Pharma

Merck prepares expanded access to monthly PrEP pill early

Jul 24, 2026 10:40am
Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o

Biogen R&D vet gets in Formation—Chutes & Ladders

Jul 24, 2026 8:30am
Sanofi

Sanofi won't seek approval for eczema drug from Kymab buyout

Jul 24, 2026 5:13am
More News

Scribe records upsized $129M IPO to fund genetic med trials

Jul 24, 2026 4:00am

Scancell heads to Nasdaq via reverse merger with Neuphoria

Jul 23, 2026 10:13am

Lilly triple-G drug hits 22% weight loss, cardio impact unclear

Jul 23, 2026 9:06am

Australia's Clinuvel to shed up to 20% of workforce in US move

Jul 23, 2026 5:47am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings